Peptic Ulcer Disease IV: Management
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
Tonsillitis II: Management
Inflammatory Bowel Disease V: Surgical Management
Acute Pharyngitis
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 18, 2026

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
Paul Brocklehurst1, Martin Tickle, Anne-Marie Glenny
1School of Dentistry, The University of Manchester, Manchester, UK. paul.brocklehurst@manchester.ac.uk
Systemic treatments for recurrent aphthous stomatitis (RAS) lack sufficient evidence for effectiveness. More high-quality research is needed to determine the best interventions for reducing pain, duration, and frequency of oral ulcers.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: